Region: Global
Category: Diagnostics

Global Diagnostics

(6,906 reports matching your criteria)
  • Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2025

    ... positron emission tomography (pet) nuclear medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to ... Read More

  • Microfluidic Devices Global Market Report 2025

    ... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More

  • Molecular Diagnostics

    ... CAGR of 9.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$16.0 Billion by the end of the ... Read More

  • Radiopharmaceuticals

    ... 11.0% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in ... Read More

  • Plastic Films

    ... CAGR of 5.8% over the analysis period 2024-2030. LLDPE, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$93.5 Billion by the end of the analysis period. ... Read More

  • Ophthalmology Picture Archiving and Communication Systems

    ... reach US$211.3 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Integrated PACS, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach ... Read More

  • Industrial X-Ray Inspection Systems

    ... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Digital, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$916.0 Million by the end ... Read More

  • Diagnostic Imaging

    ... CAGR of 5.1% over the analysis period 2024-2030. X-ray Imaging, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.4 Billion by the end of the analysis ... Read More

  • Brachytherapy

    ... 4.3% over the analysis period 2024-2030. High Dose Rate, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis period. ... Read More

  • Automated and Rapid Microbiological Tests

    ... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion ... Read More

  • Bio-MEMS Devices

    ... CAGR of 16.7% over the analysis period 2024-2030. Bio-MEMS Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis ... Read More

  • Isothermal Nucleic Acid Amplification Technology (INAAT)

    ... reach US$6.7 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$4.6 ... Read More

  • Cardiopulmonary Autotransfusion Systems

    ... at a CAGR of 2.2% over the analysis period 2024-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end ... Read More

  • X-Ray Photoelectron Spectroscopy

    ... at a CAGR of 4.8% over the analysis period 2024-2030. Healthcare, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by the end of the ... Read More

  • Particle Therapy

    ... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More

  • Vendor Neutral Archives

    ... at a CAGR of 6.5% over the analysis period 2024-2030. On-Premises, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$552.5 Million by the end of the ... Read More

  • Blood Group Typing

    ... at a CAGR of 9.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$2.8 Billion by the end of the ... Read More

  • Prostate Cancer Diagnostics

    ... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of the ... Read More

  • X-ray Inspection Systems

    ... at a CAGR of 6.0% over the analysis period 2024-2030. Digital Imaging, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$925.2 Million by the end of ... Read More

  • Portable Ultrasound Equipment

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Cart / Trolley-Based, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.4 Billion by the end ... Read More

  • Vendor Neutral Archive (VNA) and PACS

    ... reach US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. PACS, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.4 ... Read More

  • Ophthalmic Ultrasound Systems

    ... at a CAGR of 3.9% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of the ... Read More

  • Biosensors

    ... 7.2% over the analysis period 2024-2030. Non-wearable, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth in ... Read More

  • Blood Gas and Electrolyte Analyzers

    ... Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$823.6 Million by ... Read More

  • Nucleic Acid Testing

    ... at a CAGR of 4.5% over the analysis period 2024-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings